Sign in

CIK 0001770121

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Sana Biotechnology, Inc.

Sign in to watch
Ticker
SANA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831381173
Phone
+1 206-701-7914
Business address
188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +90,000 90,000
2025-06-05 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2024-06-06 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2024-06-06 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +54,278 54,278
2023-06-08 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2022-06-06 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +65,000 65,000
2021-02-03 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +11,795 11,795
2021-02-03 REICIN ALISE Director Grant or award · Stock Option (Right to Buy) +7,000 7,000

Page 1 of 1 · 8 trades